Monthly unannounced pill counts for monitoring HIV treatment adherence: Tests for self-monitoring and reactivity effects

HIV Clinical Trials

Volumn 11, Issue 6, 2010, Pages 325-331

  Kalichman, Seth C ^a   Amaral, Christina ^a   Swetsze, Connie ^a   Eaton, Lisa ^a   Kalichman, Moira O ^a   Cherry, Chauncey ^a   Detorio, Mervi ^b,c   Caliendo, Angela M ^b   Schinazi, Raymond F ^b,c  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ATLANTA VA MEDICAL CENTER   (United States)

Author keywords

adherence monitoring; assessment reactivity; HIV treatment adherence; self monitoring

Indexed keywords

ANTIRETROVIRUS AGENT;

ARTICLE; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PRIORITY JOURNAL; SELF MONITORING; SOCIAL SUPPORT; VIRUS LOAD;

ADULT; AGED; ANTI-RETROVIRAL AGENTS; COHORT STUDIES; FEMALE; HEALTH BEHAVIOR; HIV INFECTIONS; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; SELF MEDICATION; SOCIAL SUPPORT; TELEPHONE; VIRAL LOAD; YOUNG ADULT;

EID: 78751543103     PISSN: 15284336     EISSN: None     Source Type: Journal    
DOI: 10.1310/hct1106-325     Document Type: Article

References (14)

1. Dieffenbach CW, Fauci AS. Universal voluntary testing and treatment for prevention of HIV transmission. JAMA. 2009;301(22):2380-2382.
2. Bangsberg D, Kroetz DL, Deeks SG. Adherence-resistance relationships to combination HIV antiretroviral therapy. Curr HIV/AIDS Rep. 2007;4:65-72.
3. Bangsberg DR. Preventing HIV antiretroviral resistance through better monitoring of treatment adherence. J Infect Dis. 2008;197(Suppl 3):S272-278.
4. Bangsberg DR, Deeks SG. Spending more to save more: interventions to promote adherence. Ann Intern Med. 2010;152(1):54-56; W-13.
5. Rudd P, Byyny RL, Zachary V, et al. The natural history of medication compliance in a drug trial: limitations of pill counts. Clin Pharmacol Ther. 1989;46(2):169-176.
6. Pullar T, Kumar S, Tindall H, Freely M. Time to stop counting the tablets? Clin Pharmacol Ther. 1989;46(2):163-168.
7. Bangsberg DR, Perry S, Charlebois, ED, et al. Comparing objective measures of adherence to HIV antiretroviral therapy: electronic medication monitors and unannounced pill counts. AIDS Behav. 2001;5:275-281.
8. Kalichman SC, Amaral CM, Cherry C, et al. Monitoring antiretroviral adherence by unannounced pill counts conducted by telephone: reliability and criterion-related validity. HIV Clin Trials. 2008; 9:298-308.
9. Kalichman SC, Eaton L, White D, et al. Adherence to antiretroviral therapy assessed by unannounced pill counts conducted by telephone. J Gen Intern Med. 2007;22:1003-1006.
10. Kalichman SC, Amaral CM, Swetzes C, et al. A simple single-item rating scale to measure medication adherence: further evidence for convergent validity. J Int Assoc Phys AIDS Care. 2009;8(6):367-374.
11. Clifford PR, Maisto SA. Subject reactivity effects and alcohol treatment outcome research. J Stud Alcohol. 2000;61(6):787-793.
12. Picciano JF, Roffman RA, Kalichman SC, Walker DD. Lowering obstacles to HIV prevention services: effects of a brief, telephone-based intervention using motivational enhancement therapy. Ann Behav Med. 2007;34(2):177-187.
13. Kalichman SC, Kelly JA, Stevenson Y. Priming effects of HIV risk assessments on related perceptions and behaviors: an experimental fi eld study. AIDS Behav. 1997;1(1): 3-8.
14. Sabin LL, DeSilva MB, Hamer DH, et al. Using electronic drug monitor feedback to improve adherence to antiretroviral therapy among HIV-positive patients in China. AIDS Behav. 2010;14(3):580-589.